Pfizer's RSV vaccine approved by FDA for older adults.

TL;DR Summary
The FDA has approved Pfizer's RSV vaccine for older adults, making it the second vaccine approved for the common virus. RSV is highly contagious and can cause flu-like illness in people of all ages, including seniors. The Pfizer vaccine was found to be 66.7% effective at preventing moderate lower respiratory tract illness and 85.7% effective at preventing illness with three or more symptoms in people 60 and older. The vaccine could be available for seniors by fall pending recommendations from the CDC.
- FDA approves Pfizer’s RSV vaccine for older adults CNN
- New Pfizer RSV Vaccine Rolls Out Into Headwinds of Hesitancy The Wall Street Journal
- FDA approves Pfizer RSV vaccine for older adults CNBC
- F.D.A. Approves Pfizer's R.S.V. Vaccine for Older Adults The New York Times
- FDA approves second RSV shot for older adults The Hill
Reading Insights
Total Reads
0
Unique Readers
9
Time Saved
1 min
vs 2 min read
Condensed
73%
300 → 82 words
Want the full story? Read the original article
Read on CNN